These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4014485)

  • 41. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased plasma vasopressin in sinoaortic denervated rats.
    Alexander N; Morris M
    Neuroendocrinology; 1986; 42(5):361-7. PubMed ID: 3703158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide.
    Jin HK; Chen YF; Yang RH; McKenna TM; Jackson RM; Oparil S
    Am J Med Sci; 1989 Oct; 298(4):227-36. PubMed ID: 2529763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of vasopressin and the sympathetic nervous system in the cardiovascular response to vagal cold block in the conscious dog.
    Hasser EM; Haywood JR; Johnson AK; Bishop VS
    Circ Res; 1984 Oct; 55(4):454-62. PubMed ID: 6148158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water-deprived rat.
    Andrews CE; Brenner BM
    Circ Res; 1981 Feb; 48(2):254-8. PubMed ID: 7006848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of vasopressin antagonist and saralasin on regional blood flow following hemorrhage.
    Pang CC
    Am J Physiol; 1983 Nov; 245(5 Pt 1):H749-55. PubMed ID: 6688927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the cardiovascular effects of arginine vasopressin in conscious dogs.
    Tipayamontri U; Young DB; Nuwayhid BS; Scott RE
    Hypertension; 1987 Apr; 9(4):371-8. PubMed ID: 3557603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin.
    Goldberg JP; Schrier RW
    Miner Electrolyte Metab; 1984; 10(3):178-83. PubMed ID: 6727804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of intravenous AVP on cardiac output, mesenteric hemodynamics, and splanchnic nerve activity.
    Veelken R; Danckwart L; Rohmeiss P; Unger T
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H658-64. PubMed ID: 2764146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular role of vasopressin in the presence and absence of influence from angiotensin II or alpha-adrenergic system.
    Tabrizchi R; King KA; Pang CC
    Can J Physiol Pharmacol; 1986 Aug; 64(8):1143-8. PubMed ID: 3024790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vagal regulation of arginine vasopressin in conscious dogs.
    Morita H; Manders WT; Skelton MM; Cowley AW; Vatner SF
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H19-23. PubMed ID: 3728695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular response to vasopressin vasopressor antagonist administration during water deprivation in the rat.
    Rockhold RW; Share L; Crofton JT; Brooks DP
    Neuroendocrinology; 1984 Feb; 38(2):139-44. PubMed ID: 6546972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasopressin and angiotensin in the control of arterial pressure and regional blood flow in anaesthetized, surgically stressed rats.
    Pang CC
    Can J Physiol Pharmacol; 1983 Dec; 61(12):1494-500. PubMed ID: 6689477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haemodynamic effects of vasopressin in man are related to posture.
    Simpson HC; Zubillaga JE; Collier JG; Bennett ED; Ang VT; Mehta N; Jenkins JS
    Clin Sci (Lond); 1986 Feb; 70(2):177-84. PubMed ID: 3956107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular tone influences arterial pressure lability after sinoaortic deafferentation.
    Jacob HJ; Alper RH; Grosskreutz CL; Lewis SJ; Brody MJ
    Am J Physiol; 1991 Feb; 260(2 Pt 2):R359-67. PubMed ID: 1996723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.